Literature DB >> 22392288

Therapy: localized gastric cancer--a CLASSIC shift in the paradigm?

Mariela A Blum, Jaffer A Ajani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22392288     DOI： 10.1038/nrgastro.2012.35

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.

Authors:  Mitsuru Sasako; Shinichi Sakuramoto; Hitoshi Katai; Taira Kinoshita; Hiroshi Furukawa; Toshiharu Yamaguchi; Atsushi Nashimoto; Masashi Fujii; Toshifusa Nakajima; Yasuo Ohashi
Journal:  J Clin Oncol       Date:  2011-10-17       Impact factor: 44.544

2.  Gastric cancer: apples will always be apples.

Authors:  Jaffer A Ajani; Mariela A Blum; Jeannelyn S Estrella; Prajnan Das; Keith F Fournier
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544

3.  Gene expression signature-based prognostic risk score in gastric cancer.

Authors:  Jae Yong Cho; Jae Yun Lim; Jae Ho Cheong; Yun-Yong Park; Se-Lyun Yoon; Soo Mi Kim; Sang-Bae Kim; Hoguen Kim; Soon Won Hong; Young Nyun Park; Sung Hoon Noh; Eun Sung Park; In-Sun Chu; Waun Ki Hong; Jaffer A Ajani; Ju-Seog Lee
Journal:  Clin Cancer Res       Date:  2011-03-29       Impact factor: 12.531

4.  Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

Authors:  Jeeyun Lee; Do Hoon Lim; Sung Kim; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Min Gew Choi; Tae Sung Sohn; Jae Hyung Noh; Jae Moon Bae; Yong Chan Ahn; Insuk Sohn; Sin Ho Jung; Cheol Keun Park; Kyoung-Mee Kim; Won Ki Kang
Journal:  J Clin Oncol       Date:  2011-12-19       Impact factor: 44.544

5.  Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.

Authors:  Iain Beehuat Tan; Tatiana Ivanova; Kiat Hon Lim; Chee Wee Ong; Niantao Deng; Julian Lee; Sze Huey Tan; Jeanie Wu; Ming Hui Lee; Chia Huey Ooi; Sun Young Rha; Wai Keong Wong; Alex Boussioutas; Khay Guan Yeoh; Jimmy So; Wei Peng Yong; Akira Tsuburaya; Heike Grabsch; Han Chong Toh; Steven Rozen; Jae Ho Cheong; Sung Hoon Noh; Wei Kiat Wan; Jaffer A Ajani; Ju-Seog Lee; Manuel Salto Tellez; Patrick Tan
Journal:  Gastroenterology       Date:  2011-04-28       Impact factor: 22.682

6.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

7.  Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Authors:  Yung-Jue Bang; Young-Woo Kim; Han-Kwang Yang; Hyun Cheol Chung; Young-Kyu Park; Kyung Hee Lee; Keun-Wook Lee; Yong Ho Kim; Sang-Ik Noh; Jae Yong Cho; Young Jae Mok; Yeul Hong Kim; Jiafu Ji; Ta-Sen Yeh; Peter Button; Florin Sirzén; Sung Hoon Noh
Journal:  Lancet       Date:  2012-01-07       Impact factor: 79.321

8.  Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma.

Authors:  Michael W Kattan; Martin S Karpeh; Madhu Mazumdar; Murray F Brennan
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

9.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Authors:  Shinichi Sakuramoto; Mitsuru Sasako; Toshiharu Yamaguchi; Taira Kinoshita; Masashi Fujii; Atsushi Nashimoto; Hiroshi Furukawa; Toshifusa Nakajima; Yasuo Ohashi; Hiroshi Imamura; Masayuki Higashino; Yoshitaka Yamamura; Akira Kurita; Kuniyoshi Arai
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

10.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245
  10 in total
  1 in total

1.  Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively.

Authors:  Nikolaos Charalampakis; Lianchun Xiao; Elena Elimova; Roopma Wadhwa; Hironori Shiozaki; Yusuke Shimodaira; Mariela A Blum; Venkatram Planjery; Jane E Rogers; Aurelio Matamoros; Tara Sagebiel; Prajnan Das; Jeffrey H Lee; Manoop S Bhutani; Brian Weston; Jeannelyn S Estrella; Brian D Badgwell; Jaffer A Ajani
Journal:  Oncology       Date:  2015-09-23       Impact factor: 2.935
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.